Actively Recruiting
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
Led by Nanchong Central Hospital · Updated on 2026-03-31
382
Participants Needed
1
Research Sites
239 weeks
Total Duration
On this page
Sponsors
N
Nanchong Central Hospital
Lead Sponsor
G
Guang'an Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multi-center, prospective, randomized controlled study aimed at compareing the impact of stapler reinforcement patches versus standard staplers on postoperative complications in gastrojejunostomy.
CONDITIONS
Official Title
Stapler Reinforcement Patches Compared to Standard Staplers in Gastrojejunostomy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 85 years
- Pathologically diagnosed with gastric cancer and suitable for distal gastrectomy or subtotal gastrectomy
- ECOG performance status of 0 or 1
- ASA classification of I-III
- Voluntary signed informed consent from the participant or their legal representative
You will not qualify if you...
- Evidence of potential distant metastasis found preoperatively
- History of other malignancies diagnosed within the past 5 years, or any malignancy treated with chemotherapy or radiotherapy
- Significant contraindications for surgery (e.g., severe liver or kidney dysfunction)
- Participation in any other clinical trial within the last 6 months
- Participants or their legal representatives unwilling to sign the informed consent or comply with the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunhong Tian
Nanchong, Sichuan, China, 637000
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here